Avraham Raz
Avraham Raz
Verified email at
Cited by
Cited by
Participation of p53 cellular tumour antigen in transformation of normal embryonic cells
D Eliyahu, A Raz, P Gruss, D Givol, M Oren
Nature 312 (5995), 646-649, 1984
Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family
S Akahani, P Nangia-Makker, H Inohara, HRC Kim, A Raz
Cancer research 57 (23), 5272-5276, 1997
Galectin-3 induces endothelial cell morphogenesis and angiogenesis
P Nangia-Makker, Y Honjo, R Sarvis, S Akahani, V Hogan, KJ Pienta, ...
The American journal of pathology 156 (3), 899-909, 2000
Murine models to evaluate novel and conventional therapeutic strategies for cancer
JE Talmadge, RK Singh, IJ Fidler, A Raz
The American journal of pathology 170 (3), 793-804, 2007
Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin
P Nangia-Makker, V Hogan, Y Honjo, S Baccarini, L Tait, R Bresalier, ...
Journal of the National Cancer Institute 94 (24), 1854-1862, 2002
Endogenous galactoside-binding lectins: a new class of functional tumor cell surface molecules related to metastasis
A Raz, R Lotan
Cancer and Metastasis Reviews 6 (3), 433-452, 1987
CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis
T Fukumori, Y Takenaka, T Yoshii, HRC Kim, V Hogan, H Inohara, ...
Cancer research 63 (23), 8302-8311, 2003
Galectin-3 and metastasis
Y Takenaka, T Fukumori, A Raz
Glycoconjugate journal 19 (7), 543-549, 2002
Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin
KJ Pienta, H Nailk, A Akhtar, K Yamazaki, TS Replogle, J Lehr, TL Donat, ...
JNCI: Journal of the National Cancer Institute 87 (5), 348-353, 1995
Galectin-3 translocates to the perinuclear membranes and inhibits cytochrome c release from the mitochondria: a role for synexin in galectin-3 translocation
F Yu, RL Finley, A Raz, HRC Kim
Journal of Biological Chemistry 277 (18), 15819-15827, 2002
Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells
HRC Kim, HM Lin, H Biliran, A Raz
Cancer research 59 (16), 4148-4154, 1999
On the role of galectin-3 in cancer apoptosis
S Nakahara, N Oka, A Raz
Apoptosis 10 (2), 267-275, 2005
Analysis of the fate of systemically administered liposomes and implications for their use in drug delivery
G Poste, C Bucana, A Raz, P Bugelski, R Kirsh, IJ Fidler
Cancer Research 42 (4), 1412-1422, 1982
On the role of cell surface carbohydrates and their binding proteins (lectins) in tumor metastasis
E Gorelik, U Galili, A Raz
Cancer and Metastasis Reviews 20 (3), 245-277, 2001
Interactions between galectin-3 and Mac-2-binding protein mediate cell-cell adhesion
H Inohara, S Akahani, K Koths, A Raz
Cancer research 56 (19), 4530-4534, 1996
Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest
T Yoshii, T Fukumori, Y Honjo, H Inohara, HRC Kim, A Raz
Journal of biological chemistry 277 (9), 6852-6857, 2002
Modified citrus pectin anti-metastatic properties: one bullet, multiple targets
VV Glinsky, A Raz
Carbohydrate research 344 (14), 1788-1791, 2009
Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide
H Watanabe, K Takehana, M Date, T Shinozaki, A Raz
Cancer research 56 (13), 2960-2963, 1996
Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and-9
J Ochieng, R Fridman, P Nangia-Makker, DE Kleiner, LA Liotta, ...
Biochemistry 33 (47), 14109-14114, 1994
Proteases, extracellular matrix, and cancer: a workshop of the path B study section
YA DeClerck, AM Mercurio, MS Stack, HA Chapman, MM Zutter, ...
The American journal of pathology 164 (4), 1131-1139, 2004
The system can't perform the operation now. Try again later.
Articles 1–20